IIT2022-05-Sankar-BELIEVE: Phase II Study of Bevacizumab in Combination With Chemoimmunotherapy and Maintenance Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
Latest Information Update: 14 May 2025
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary) ; Carboplatin (Primary) ; Etoposide (Primary)
- Indications Liver metastases; Small cell lung cancer
- Focus Therapeutic Use
- Acronyms BELIEVE; IIT2022-05-Sankar-BELIEVE
Most Recent Events
- 22 Jan 2025 Planned End Date changed from 28 Sep 2027 to 28 Dec 2027.
- 22 Jan 2025 Planned primary completion date changed from 28 Sep 2026 to 28 Dec 2026.
- 31 Jul 2024 Planned initiation date changed from 1 Feb 2024 to 1 Aug 2024.